Self-administration of Aspirin for Acute Chest Pain-Does It Prevent Premature Cardiovascular Mortality?

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2024 Dec 17

PMID 39688630

Authors

Gudrun Lamm

Affiliations

Soon will be listed here.

Abstract

Aspirin as a class I guideline recommended medical treatment for acute coronary syndrome has been established for decades [1]. As early intake of aspirin is crucial, self-administration of aspirin in acute chest pain might be beneficial when weighing up the potential harm including a slightly elevated bleeding risk in patients with chest pain of another origin than myocardial infarction against the benefit in patients with coronary ischemia.

References

Byrne R, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A . 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023; 44(38):3720-3826. DOI: 10.1093/eurheartj/ehad191. View

Weiss H, Aledort L . Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967; 2(7514):495-7. DOI: 10.1016/s0140-6736(67)91658-3. View

Awtry E, Loscalzo J . Aspirin. Circulation. 2000; 101(10):1206-18. DOI: 10.1161/01.cir.101.10.1206. View

McNeil J, Wolfe R, Woods R, Tonkin A, Donnan G, Nelson M . Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly. N Engl J Med. 2018; 379(16):1509-1518. PMC: 6289056. DOI: 10.1056/NEJMoa1805819. View

Gaziano J, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick P . Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018; 392(10152):1036-1046. PMC: 7255888. DOI: 10.1016/S0140-6736(18)31924-X. View

Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J . Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018; 379(16):1529-1539. DOI: 10.1056/NEJMoa1804988. View

Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R . Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-60. PMC: 2715005. DOI: 10.1016/S0140-6736(09)60503-1. View

Tataris K, Mercer M, Govindarajan P . Prehospital aspirin administration for acute coronary syndrome (ACS) in the USA: an EMS quality assessment using the NEMSIS 2011 database. Emerg Med J. 2015; 32(11):876-81. DOI: 10.1136/emermed-2014-204299. View

Gurbel P, Bliden K, Kundan P, Kraft D, Parekh R, Singh S . Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response. J Thromb Thrombolysis. 2023; 57(1):21-28. PMC: 10830588. DOI: 10.1007/s11239-023-02914-7. View

10.

Santos R, Goulart A, Kisukuri A, Brandao R, Sitnik D, Staniak H . Time-To-Treatment of Acute Coronary Syndrome and Unit of First Contact in the ERICO Study. Arq Bras Cardiol. 2016; 107(4):323-330. PMC: 5102478. DOI: 10.5935/abc.20160138. View

11.

Freimark D, Matetzky S, Leor J, Boyko V, Barbash I, Behar S . Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol. 2002; 89(4):381-5. DOI: 10.1016/s0002-9149(01)02256-1. View

12.

Nordt S, Clark R, Castillo E, Guss D . Comparison of three aspirin formulations in human volunteers. West J Emerg Med. 2012; 12(4):381-5. PMC: 3236147. DOI: 10.5811/westjem.2011.4.2222. View

13.

Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L . Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet. Int J Clin Pharmacol Ther. 2022; 60(10):430-438. PMC: 9494154. DOI: 10.5414/CP204271. View

14.

Kaur H, Sarma P, Bhattacharyya A, Rohit M, Prajapat M, Kumar S . Role of intravenous aspirin versus oral aspirin in the treatment of acute coronary syndrome: Answering a clinical query by systematic review and meta-analysis of randomized controlled trials. Indian J Pharmacol. 2023; 55(2):133-137. PMC: 10335641. DOI: 10.4103/ijp.ijp_1147_20. View

15.

Eikelboom J, Mehta S, Anand S, Xie C, Fox K, Yusuf S . Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006; 114(8):774-82. DOI: 10.1161/CIRCULATIONAHA.106.612812. View

16.

Stone G, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Dudek D . Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008; 358(21):2218-30. DOI: 10.1056/NEJMoa0708191. View

17.

Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T . Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015; 385(9986):2465-76. DOI: 10.1016/S0140-6736(15)60292-6. View

18.

Simonsson M, Wallentin L, Alfredsson J, Erlinge D, Angerud K, Hofmann R . Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. Eur Heart J. 2019; 41(7):833-843. DOI: 10.1093/eurheartj/ehz593. View

19.

Gulati M, Levy P, Mukherjee D, Amsterdam E, Bhatt D, Birtcher K . 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Cardiovasc Comput Tomogr. 2021; 16(1):54-122. DOI: 10.1016/j.jcct.2021.11.009. View

20.

Hoorweg B, Willemsen R, Cleef L, Boogaerts T, Buntinx F, Glatz J . Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses. Heart. 2017; 103(21):1727-1732. DOI: 10.1136/heartjnl-2016-310905. View